journal
MENU ▼
Read by QxMD icon Read
search

Journal of Crohn's & Colitis

journal
https://www.readbyqxmd.com/read/28531313/mucosal-healing-in-ulcerative-colitis-patients-treated-with-vedolizumab-patient-dose-or-duration-dependant
#1
Rui Gaspar, Rodrigo Liberal, Guilherme Macedo
No abstract text is available yet for this article.
May 22, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28525622/dietary-therapy-with-the-crohn-s-disease-exclusion-diet-is-a-successful-strategy-for-induction-of-remission-in-children-and-adults-failing-biological-therapy
#2
Rotem Sigall Boneh, Chen Sarbagili-Shabat, Heinit Yanai, Irit Chermesh, Sivan Ben Avraham, Mona Boaz, Arie Levine
Background: Loss of response (LoR) to biologics in Crohn's disease (CD) is a significant clinical problem. Dietary therapy as a treatment strategy in this setting has not been previously reported. We report the use of dietary strategies using enteral nutrition coupled with the Crohn's Disease Exclusion Diet (CDED) for LoR to infliximab or adalimumab as a single center experience. Methods: Patients with LoR to a biologic despite dose escalation or combination therapy were treated with partial enteral nutrition (PEN) by a polymeric formula and the CDED for 12 weeks...
May 19, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28525593/incidence-phenotype-and-mortality-of-inflammatory-bowel-disease-twenty-years-after
#3
Franck Carbonnel, Marie Christine Boutron
No abstract text is available yet for this article.
May 19, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28525543/fermentable-carbohydrates-fodmaps-exacerbate-functional-gastrointestinal-symptoms-in-patients-with-inflammatory-bowel-disease-a-randomised-double-blind-placebo-controlled-cross-over-re-challenge-trial
#4
Selina R Cox, Alexis C Prince, Clio E Myers, Peter M Irving, James O Lindsay, Miranda C Lomer, Kevin Whelan
Background and Aims: Preliminary evidence suggests fermentable carbohydrate restriction might ameliorate functional gastrointestinal symptoms (FGS) in quiescent inflammatory bowel disease (IBD). Our aim was to determine whether fermentable carbohydrates exacerbate FGS in quiescent IBD using a randomised, double-blinded, placebo-controlled, cross-over, re-challenge trial. Methods: Patients with quiescent IBD and FGS responsive to a low FODMAP diet were allocated to a series of 3-day fermentable carbohydrate challenges in random order (fructan, 12 g/d; galacto-oligosaccharides, GOS, 6 g/d; sorbitol, 6 g/d; and glucose placebo, 12 g/d), each separated by a standardised washout period...
May 19, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28510689/chronic-enteropathy-associated-with-slco2a1-gene-ceas-characterization-of-an-enteric-disorder-to-be-considered-in-the-differential-diagnosis-of-crohn-s-disease
#5
Naoki Hosoe, Naoki Ohmiya, Fumihito Hirai, Junji Umeno, Motohiro Esaki, Hirokazu Yamagami, Kei Onodera, Shigeki Bamba, Hiroyuki Imaeda, Shunichi Yanai, Tadakazu Hisamatsu, Haruhiko Ogata, Takayuki Matsumoto
Small intestinal ulcers include mucosal damage caused by drugs, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), infectious diseases, and idiopathic inflammatory bowel disease. Previously, a group of Japanese investigators reported an unusual and uncommon type of enteritis and referred to the condition as chronic nonspecific multiple ulcers of the small intestine (CNSU). CNSU is characterized by chronic blood and protein loss through persistent small intestinal ulcers. Recently, four candidate mutations in the solute carrier organic anion transporter family, member 2A1 (SLCO2A1) gene, encoding a prostaglandin transporter, were identified by whole-exam sequencing in patients with CNSU...
May 16, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28505293/budesonide-mmx-in-pediatric-patients-with-ulcerative-colitis
#6
Katarzyna Karolewska-Bochenek, Marcin Dziekiewicz, Aleksandra Banaszkiewicz
No abstract text is available yet for this article.
May 15, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28505231/autologous-stem-cell-transplantation-for-refractory-crohn-s-disease-is-it-time-to-take-a-long-term-view
#7
J O Lindsay
No abstract text is available yet for this article.
May 15, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28498901/ecco-escp-consensus-on-surgery-for-crohn-s-disease
#8
Willem A Bemelman, Janindra Warusavitarne, Gianluca M Sampietro, Zuzana Serclova, Oded Zmora, Gaetano Luglio, Anthony de Buck van Overstraeten, John P Burke, Christianne J Buskens, Colombo Francesco, Jorge Amil Dias, Rami Eliakim, Tomás Elosua, I Ethem Gecim, Sanja Kolacek, Jaroslaw Kierkus, Kaija-Leena Kolho, Jérémie H Lefevre, Monica Millan, Yves Panis, Thomas Pinkney, Richard K Russell, Chaya Shwaartz, Carolynne Vaizey, Nuha Yassin, André D'Hoore
No abstract text is available yet for this article.
May 11, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28486648/faecal-microbiota-transplantation-for-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis
#9
Sudarshan Paramsothy, Ramesh Paramsothy, David T Rubin, Michael A Kamm, Nadeem O Kaakoush, Hazel M Mitchell, Natalia Castaño-Rodríguez
BACKGROUND: Faecal microbiota transplantation (FMT) has been investigated as a potential treatment for inflammatory bowel disease (IBD). We thus performed a systematic review and meta-analysis assessing the effectiveness and safety of FMT in IBD. METHODS: A systematic review was conducted until Jan 2017. Studies were excluded if patients had co-infection or data was pooled across disease subtypes (ulcerative colitis (UC), Crohn's disease (CD), pouchitis). Clinical remission was established as the primary outcome...
May 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28486634/patient-education-in-a-14-month-randomized-trial-fails-to-improve-adherence-in-ulcerative-colitis-influence-of-demographic-and-clinical-parameters-on-non-adherence
#10
S Nikolaus, S Schreiber, B Siegmund, B Bokemeyer, E Bästlein, O Bachmann, D Görlich, U Hofmann, M Schwab, W Kruis
Background: Recent observational studies document that non-adherence to mesalamine therapy during remission is frequent. Aim: To investigate patient impact of patient education using objective assessments of adherence. Design: A 14-month randomized, prospective clinical trial of adherence to mesalamine was conducted in 248 patients with UC (CAI ≤ 9) receiving standard care (n= 122) versus a standardized patient education programme (n= 126)...
May 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28486626/proximal-disease-extension-in-patients-with-limited-ulcerative-colitis-a-danish-population-based-inception-cohort
#11
J Burisch, R Ungaro, I Vind, M V Prosberg, F Bendtsen, J-F Colombel, M K Vester-Andersen
Background and aims: Disease extent in ulcerative colitis (UC) is dynamic and can progress over time. Little is known about risk factors for UC extension in the era of biologics. We investigated the risk of UC extension and subsequent risk of surgery in a Danish population-based cohort. Methods: All incident UC cases in a strictly defined Copenhagen area between 2003 and 2004 were followed prospectively through 2011. Disease extension was defined as patients with limited UC (E1 or E2) at diagnosis having progressed from the initial extent by colonoscopy or surgery to E2 or extensive colitis (E3)...
May 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28486597/patency-capsule-safety-in-crohn-s-disease
#12
Marco Silva, Hélder Cardoso, Guilherme Macedo
No abstract text is available yet for this article.
May 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28486576/alfaebeta7-integrin-expression-on-t-cells-in-ulcerative-colitis
#13
Carmen S Horjus Talabur Horje
No abstract text is available yet for this article.
May 9, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28482085/safety-of-anti-tnf-treatment-in-liver-transplant-recipients-a-systematic-review-and-meta-analysis
#14
M J Westerouen van Meeteren, B Hayee, A Inderson, A E van der Meulen, R Altwegg, B van Hoek, G P Pageaux, T Stijnen, D Stein, P W J Maljaars
Methods: A search was conducted for full papers and conference proceedings through September 2015 regarding liver transplant recipients and anti-TNF therapy. All studies were appraised using the adapted Newcastle-Ottawa Scale (NOS). Two reviewers independently extracted patient data (age, duration of follow up, number of all infections, number of serious infections, time since transplant). As additional control population, PSC-IBD patients from the LUMC LT cohort were used. Poisson regression was used to compare serious infections (according to ICH-definition) per patient year follow up between the anti-TNF and control group...
May 6, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28472424/ven-120-a-recombinant-human-lactoferrin-promotes-a-regulatory-t-cell-treg-phenotype-and-drives-resolution-of-inflammation-in-distinct-murine-models-of-inflammatory-bowel-disease
#15
Christopher F MacManus, Colm B Collins, Tom T Nguyen, Randall W Alfano, Paul Jedlicka, Edwin F de Zoeten
Background and Aims: Inflammatory bowel disease (IBD) is characterized by a disruption of immune homeostasis, which is tightly regulated to protect against harmful pathogens yet not react to commensal antigens. Animal studies indicate that regulatory T cells (Treg) modulate the immune response to prevent IBD development. Lactoferrin (LF), is an endogenous anti-inflammatory pleiotropic protein secreted at high concentrations in colostrum and at mucosal sites. However, the effect of LF on specific T lymphocyte populations has not been studied...
May 2, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28472257/expression-of-ecto-nucleoside-triphosphate-diphosphohydrolases-2-and-3-in-the-enteric-nervous-system-impacts-inflammation-in-experimental-colitis-and-crohn-s-disease
#16
Linda Feldbrügge, Alan C Moss, Eric U Yee, Eva Csizmadia, Shuji Mitsuhashi, Maria Serena Longhi, Bynvant Sandhu, Holger Stephan, Yan Wu, Adam S Cheifetz, Christa E Müller, Jean Sévigny, Simon C Robson, Z Gordon Jiang
Objective: Recent studies have suggested that the enteric nervous system can modulate gut immunity. Ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases) regulate purinergic signaling by sequential phosphohydrolysis of pro-inflammatory extracellular ATP. Herein, we test the hypothesis that E-NTPDases modulate gut inflammation via neuro-immune crosstalk. Design: We determined expression patterns of NTPDase2 and NTPDase3 in murine and human colon. Experimental colitis was induced by dextran sodium sulfate (DSS) in genetically engineered mice deficient in NTPDase2 or NTPDase3...
May 2, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28453665/corrigendum
#17
(no author information available yet)
No abstract text is available yet for this article.
April 27, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28444254/the-effect-of-biosimilars-inflectra%C3%A2-in-the-management-of-acute-severe-ulcerative-colitis
#18
Grace Harkin, Áine Keogh, Eoin Slattery
No abstract text is available yet for this article.
April 24, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28430884/a-20-year-temporal-change-analysis-in-incidence-presenting-phenotype-and-mortality-in-the-dutch-ibdsl-cohort-can-diagnostic-factors-explain-the-increase-in-ibd-incidence
#19
Tim R A van den Heuvel, Steven F G Jeuring, Maurice P Zeegers, Dorien H E van Dongen, Anouk Wolters, Ad A M Masclee, Wim H Hameeteman, Marielle J L Romberg-Camps, Liekele E Oostenbrug, Marieke J Pierik, Daisy M Jonkers
Background: The aim was to study temporal changes in incidence, disease phenotype at diagnosis, and mortality of adult inflammatory bowel disease (IBD) patients in South Limburg, the Netherlands, diagnosed between 1991 and 2010. In addition, the 2010 IBD prevalence was estimated. Methods: A multi-faceted approach including hospital administrations, the national pathology registry, and general practitioners led to the identification of 1162 patients with Crohn's disease (CD), 1663 with ulcerative colitis (UC) and 84 with unclassified IBD (IBD-U)...
April 20, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28430891/development-and-validation-of-diagnostic-criteria-for-ibd-subtypes-with-an-emphasis-on-ibd-unclassified-in-children-a-multicenter-study-from-the-pediatric-ibd-porto-group-of-espghan
#20
Liron Birimberg-Schwartz, David M Zucker, Amichay Akriv, Salvatore Cucchiara, Fiona L Cameron, David C Wilson, Iza Lazowska, Lambri Yianni, Siba Prosad Paul, Claudio Romano, Sanja Kolacek, Stephan Buderus, Anders Pærregaard, Richard K Russell, Johanna C Escher, Dan Turner
Background: The revised Porto criteria identify subtypes of pediatric inflammatory bowel diseases: ulcerative colitis (UC), atypical UC, Inflammatory Bowel Disease Unclassified (IBDU), and Crohn's disease (CD). In continuation of the Porto criteria, we aimed to derive and validate criteria for standardizing the classification of the IBD subtypes. Methods: This was a multicenter retrospective longitudinal study from 23 centers affiliated with the Porto-group of ESPGHAN...
April 18, 2017: Journal of Crohn's & Colitis
journal
journal
41775
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"